Results 121 to 130 of about 18,680 (257)

Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added 123I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity [PDF]

, 2008
Hein J. Verberne, Ellinor Busemann Sokole, Astrid F. van Moerkerken, Joop H. W. M. Deeterink, Geert Ensing, Michael G. Stabin, G. Aernout Somsen, Berthe L.F. van Eck‐Smit   +7 more
openalex   +1 more source

123I-mIBG: Simplicity and reproducibility [PDF]

Journal of Nuclear Cardiology, 2019
Kevin, Curl, Christopher L, Hansen
openaire   +2 more sources

Supplemental from Imaging the Norepinephrine Transporter in Neuroblastoma: A Comparison of [¹⁸F]-MFBG and ¹²³I-MIBG

, 2023
Hanwen Zhang, Ruimin Huang, Nai‐Kong V. Cheung, Hong-Fen Guo, Pat Zanzonico, Howard T. Thaler, Jason S. Lewis, Ronald G. Blasberg   +7 more
openalex   +1 more source

Efetividade da radioiodoterapia com 131I-metaiodobenzilguanidina (131I-MIBG) para o tratamento do neuroblastoma

, 2023
Roberto Carlos Lyra da Silva, Carlos Roberto Lyra da Silva, Ayla Maria Farias de Mesquita, Ana Paula Rodrigues Siqueira, Jéssica Silva Brunoni, Lilian Reinaldi Ribeiro Pirozi, Regina Bokehi Nigri   +6 more
openalex   +2 more sources

α-synuclein seed amplification assay sensitivity may be associated with cardiac MIBG abnormality among patients with Lewy body disease

npj Parkinson's Disease
Although α-synuclein seed amplification assays (α-syn SAA) are promising, its sensitivity may be affected by heterogeneity among patients with Lewy body disease (LBD). We evaluated whether α-syn SAA sensitivity is affected by patient heterogeneity, using
Masanori Kurihara, Katsuya Satoh, Ryosuke Shimasaki, Keiko Hatano, Kensuke Ohse, Kenichiro Taira, Ryoko Ihara, Mana Higashihara, Yasushi Nishina, Masashi Kameyama, Atsushi Iwata   +10 more
doaj   +1 more source

Relationship between Plasma Norepinephrine at Peak Exercise and 123I-MIBG Imaging of the Heart and Lower Limbs in Heart Failure

, 2007
Takaya Tsuchida, Nagaharu Fukuma, Keiko Oikawa, Kazuyo Kato, Yuko Kato, Teruo Takano, Shin‐ichiro Kumita   +6 more
openalex   +2 more sources

A model for in situ plan of care for a critically unstable pediatric patient following I‐131 MIBG infusion [PDF]

, 2020
Heidi R. Flori, Rama Mwenesi, Annette Scott, Christina Marie Conrad, Justin Andrew Quinn, Waseem Ostwani, Karl William Fischer, Gregory A. Yanik   +7 more
openalex   +1 more source

Opsoclonus myoclonus syndrome: how long are we going to go on researching?] [PDF]

, 2002
Rev Neurol. 2002 Aug 16-31;35(4):322-5. [Opsoclonus myoclonus syndrome: how long are we going to go on researching?] [Article in Spanish] Ramos S, Temudo T. Interna complementar de Pediatria. Serviço de Pediatria.
Ramos, S., Temudo, T.
core  

Secondary childhood acute myeloid leukemia with complex karyotypic anomalies including monosomy 7, monosomy 5 and translocation (1;10) after 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma

The Turkish Journal of Pediatrics, 2011
The prognosis for relapsing or refractory neuroblastoma (NB) remains dismal, with a five-year disease-free survival of < 20%, and no effective salvage treatment has been identified so far.
Sonay Incesoy-Ozdemir, Ceyhun Bozkurt, Nazmiye Yüksek, Ayşe Ceyda Oren, Gürses Sahin, Süreyya Bozkurt, Ulya Ertem   +6 more
doaj  

Radioterapia interna con metayodobencilguanidina 131I-MIBG

Momento, 2002
Se calcula la dosis absorbida en los órganos que intervienen en el metabolismo de 131I-MIBG en función de la masa de cada uno. Se sigue el formalismo planteado por la Comisión Internacional de Protección Radiológica ICRP, según el cual, la dosis absorbida se obtiene como el producto de la energía por unidad de masa, S ...
Machado, Harold, Chica, Luis G.
openaire   +2 more sources